Melatonin, programmed death ligand-1, programmed death ligand-1, and cancer: imagine beyond the future?
作者信息
Soares Junior José Maria, Sengul Ilker, Sengul Demet
机构信息
Universidade de São Paulo, Hospital das Clínicas, Faculdade de Medicina, Departamento de Obstetrícia e Ginecologia, Disciplina de Ginecologia, Laboratório de Ginecologia Estrutural e Molecular (LIM-58) - São Paulo (SP), Brazil.
Giresun University, Faculty of Medicine, Division of Endocrine Surgery - Giresun, Turkey.
出版信息
Rev Assoc Med Bras (1992). 2025 May 2;71(3):e0713EDIT. doi: 10.1590/1806-9282.0713EDIT. eCollection 2025.
Abstract
摘要
相似文献
1
Melatonin, programmed death ligand-1, programmed death ligand-1, and cancer: imagine beyond the future?褪黑素、程序性死亡配体-1、程序性死亡配体-1与癌症：畅想未来之外？
Rev Assoc Med Bras (1992). 2025 May 2;71(3):e0713EDIT. doi: 10.1590/1806-9282.0713EDIT. eCollection 2025.
2
β-catenin and PD-L1 expression in mismatch repair deficient endometrial carcinomas.β-连环蛋白和 PD-L1 在错配修复缺陷型子宫内膜癌中的表达。
Int J Gynecol Cancer. 2020 Jul;30(7):993-999. doi: 10.1136/ijgc-2020-001239. Epub 2020 May 5.
3
Expression of programmed death ligand 1 in drug-resistant osteosarcoma: An exploratory study.程序性死亡配体1在耐药骨肉瘤中的表达：一项探索性研究。
Surg Open Sci. 2021 Jul 14;6:10-14. doi: 10.1016/j.sopen.2021.07.001. eCollection 2021 Oct.
4
Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon.黎巴嫩非小细胞肺癌患者程序性死亡配体-1的患病率。
SAGE Open Med. 2021 Sep 8;9:20503121211043709. doi: 10.1177/20503121211043709. eCollection 2021.
5
Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy.血清可溶性程序性死亡配体 1 浓度升高可作为小细胞肺癌患者化疗预后不良的潜在标志物。
Respir Res. 2018 Oct 5;19(1):197. doi: 10.1186/s12931-018-0885-x.
6
Comparison of programmed death ligand-1 expression in preoperative transbronchial lung biopsy and resected specimens in non-small cell lung cancer.非小细胞肺癌患者术前经支气管肺活检与手术切除标本中程序性死亡配体-1表达的比较。
J Cancer Res Clin Oncol. 2025 Apr 14;151(4):139. doi: 10.1007/s00432-025-06189-8.
7
Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化中程序性细胞死亡蛋白1/程序性细胞死亡配体1轴的调控
Brain Commun. 2023 Jul 25;5(4):fcad206. doi: 10.1093/braincomms/fcad206. eCollection 2023.
8
PD-L1 and CD8+ T cell evaluation in breast cancers and their correlation with clinicopathological parameters.PD-L1 和 CD8+T 细胞在乳腺癌中的评估及其与临床病理参数的相关性。
J Pak Med Assoc. 2024 Jul;74(7):1274-1279. doi: 10.47391/JPMA.10567.
9
Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer.程序性细胞死亡蛋白1、程序性细胞死亡配体1、程序性细胞死亡配体2和成纤维细胞生长因子受体3 mRNA表达在膀胱癌中的预后意义
Pathobiology. 2025 Feb 26:1-14. doi: 10.1159/000544733.
10
PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.在胃癌中，程序性死亡受体配体1（PD-L1）的表达主要受与JAK-STAT信号通路相关的γ干扰素调控。
Cancer Sci. 2018 Jan;109(1):43-53. doi: 10.1111/cas.13424. Epub 2017 Nov 18.
本文引用的文献
1
Of sight, and insight into melatonin's role in breast cancer?关于褪黑素在乳腺癌中的作用的见解以及视觉方面呢？
Rev Assoc Med Bras (1992). 2023 Jul 17;69(7):e697EDIT. doi: 10.1590/1806-9282.697EDIT. eCollection 2023.
2
Of sight, and insight.关于视力与洞察力。
Lancet. 2023 Jan 14;401(10371):97. doi: 10.1016/S0140-6736(22)02589-2. Epub 2022 Dec 21.
3
Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells.褪黑素通过源自胃癌细胞的外泌体靶向巨噬细胞程序性死亡配体1（PD-L1）来增强抗肿瘤免疫力。
Mol Cell Endocrinol. 2023 Jun 1;568-569:111917. doi: 10.1016/j.mce.2023.111917. Epub 2023 Apr 5.
4
Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy.程序性细胞死亡蛋白-1 及其配体：免疫治疗的最新知识和可能性。
Clinics (Sao Paulo). 2023 Mar 14;78:100177. doi: 10.1016/j.clinsp.2023.100177. eCollection 2023.
5
Repercussion of thyroid dysfunctions in thyroidology on the reproductive system: Conditio sine qua non?甲状腺学中甲状腺功能障碍对生殖系统的影响：必要条件？
Rev Assoc Med Bras (1992). 2022 Jun 24;68(6):721-722. doi: 10.1590/1806-9282.20220255. eCollection 2022.
6
Connection of reactive oxygen species as an essential actor for the mechanism of phenomena; ischemic preconditioning and postconditioning: Come to age or ripening?活性氧作为现象机制的关键因素的联系；缺血预处理和后处理：是走向成熟还是已然成熟？
North Clin Istanb. 2021 Dec 31;8(6):644-649. doi: 10.14744/nci.2021.78466. eCollection 2021.
7
Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points.卵巢癌的免疫疗法，尤其着重于以PD-1/PDL-1为靶点
Cancers (Basel). 2021 Dec 1;13(23):6063. doi: 10.3390/cancers13236063.
8
Immune checkpoint inhibitors in ovarian cancer: where do we stand?卵巢癌中的免疫检查点抑制剂：我们目前的进展如何？
Ther Adv Med Oncol. 2021 Aug 18;13:17588359211039899. doi: 10.1177/17588359211039899. eCollection 2021.
9
Melatonin Downregulates PD-L1 Expression and Modulates Tumor Immunity in KRAS-Mutant Non-Small Cell Lung Cancer.褪黑素下调 KRAS 突变型非小细胞肺癌中 PD-L1 的表达并调节肿瘤免疫。
Int J Mol Sci. 2021 May 26;22(11):5649. doi: 10.3390/ijms22115649.
10
PD-L1 expression with QR1 and E1L3N antibodies according to histological ovarian cancer subtype: A series of 232 cases.根据组织学卵巢癌亚型用 QR1 和 E1L3N 抗体检测 PD-L1 表达：一系列 232 例。
Eur J Histochem. 2021 Mar 10;65(1):3185. doi: 10.4081/ejh.2021.3185.
Zotero 插件